437 related articles for article (PubMed ID: 24440699)
1. Effect of amino acid variations in the central region of human serum amyloid A on the amyloidogenic properties.
Takase H; Tanaka M; Miyagawa S; Yamada T; Mukai T
Biochem Biophys Res Commun; 2014 Jan; 444(1):92-7. PubMed ID: 24440699
[TBL] [Abstract][Full Text] [Related]
2. Identification of regions responsible for heparin-induced amyloidogenesis of human serum amyloid A using its fragment peptides.
Egashira M; Takase H; Yamamoto I; Tanaka M; Saito H
Arch Biochem Biophys; 2011 Jul; 511(1-2):101-6. PubMed ID: 21569756
[TBL] [Abstract][Full Text] [Related]
3. Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis.
van der Hilst JC; Yamada T; Op den Camp HJ; van der Meer JW; Drenth JP; Simon A
Rheumatology (Oxford); 2008 Nov; 47(11):1651-4. PubMed ID: 18815155
[TBL] [Abstract][Full Text] [Related]
4. Human SAA1-derived amyloid deposition in cell culture: a consistent model utilizing human peripheral blood mononuclear cells and serum-free medium.
Ishii W; Liepnieks JJ; Yamada T; Benson MD; Kluve-Beckerman B
Amyloid; 2013 Jun; 20(2):61-71. PubMed ID: 23461622
[TBL] [Abstract][Full Text] [Related]
5. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.
Liu Y; Cui D; Hoshii Y; Kawano H; Une Y; Gondo T; Ishihara T
Scand J Immunol; 2007 Nov; 66(5):495-500. PubMed ID: 17953525
[TBL] [Abstract][Full Text] [Related]
6. In vitro amyloid fibril formation by synthetic peptides corresponding to the amino terminus of apoSAA isoforms from amyloid-susceptible and amyloid-resistant mice.
Kirschner DA; Elliott-Bryant R; Szumowski KE; Gonnerman WA; Kindy MS; Sipe JD; Cathcart ES
J Struct Biol; 1998 Dec; 124(1):88-98. PubMed ID: 9931277
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2.
Srinivasan S; Patke S; Wang Y; Ye Z; Litt J; Srivastava SK; Lopez MM; Kurouski D; Lednev IK; Kane RS; Colón W
J Biol Chem; 2013 Jan; 288(4):2744-55. PubMed ID: 23223242
[TBL] [Abstract][Full Text] [Related]
8. AA amyloidosis-resistant CE/J mice have Saa1 and Saa2 genes that encode an identical SAA isoform.
Mori M; Tiang G; Higuchi K
Amyloid; 2014 Mar; 21(1):1-8. PubMed ID: 24228751
[TBL] [Abstract][Full Text] [Related]
9. A protein AA-variant derived from a novel serum AA protein, SAA1 delta, in an individual from Papua New Guinea.
Westermark P; Sletten K; Westermark GT; Raynes J; McAdam KP
Biochem Biophys Res Commun; 1996 Jun; 223(2):320-3. PubMed ID: 8670280
[TBL] [Abstract][Full Text] [Related]
10. Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy.
Elimova E; Kisilevsky R; Szarek WA; Ancsin JB
FASEB J; 2004 Nov; 18(14):1749-51. PubMed ID: 15345688
[TBL] [Abstract][Full Text] [Related]
11. Revisiting misfolding propensity of serum amyloid A1: Special focus on the signal peptide region.
Haines MS; Ramirez E; Moore KBE; Fortin JS
Biochem Biophys Rep; 2022 Sep; 31():101284. PubMed ID: 35664543
[TBL] [Abstract][Full Text] [Related]
12. Cryo-EM demonstrates the in vitro proliferation of an ex vivo amyloid fibril morphology by seeding.
Heerde T; Rennegarbe M; Biedermann A; Savran D; Pfeiffer PB; Hitzenberger M; Baur J; Puscalau-Girtu I; Zacharias M; Schwierz N; Haupt C; Schmidt M; Fändrich M
Nat Commun; 2022 Jan; 13(1):85. PubMed ID: 35013242
[TBL] [Abstract][Full Text] [Related]
13. Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome.
van der Hilst JC; Drenth JP; Bodar EJ; Bijzet J; van der Meer JW; Simon A;
Amyloid; 2005 Jun; 12(2):115-9. PubMed ID: 16011988
[TBL] [Abstract][Full Text] [Related]
14. Serum amyloid A3 (SAA3), not SAA1 appears to be the major acute phase SAA isoform in the pig.
Soler L; Luyten T; Stinckens A; Buys N; Cerón JJ; Niewold TA
Vet Immunol Immunopathol; 2011 May; 141(1-2):109-15. PubMed ID: 21439655
[TBL] [Abstract][Full Text] [Related]
15. Acceleration of amyloid fibril formation by carboxyl-terminal truncation of human serum amyloid A.
Tanaka M; Kawakami T; Okino N; Sasaki K; Nakanishi K; Takase H; Yamada T; Mukai T
Arch Biochem Biophys; 2018 Feb; 639():9-15. PubMed ID: 29288051
[TBL] [Abstract][Full Text] [Related]
16. Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis.
Patel H; Bramall J; Waters H; De Beer MC; Woo P
Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):1041-9. PubMed ID: 8836154
[TBL] [Abstract][Full Text] [Related]
17. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1.
Liepnieks JJ; Kluve-Beckerman B; Benson MD
Biochim Biophys Acta; 1995 Jan; 1270(1):81-6. PubMed ID: 7827140
[TBL] [Abstract][Full Text] [Related]
18. Syrian and Armenian hamsters differ in serum amyloid A gene expression. Identification of novel Syrian hamster serum amyloid A subtypes.
de Beer MC; de Beer FC; Beach CM; Gonnerman WA; Carreras I; Sipe JD
J Immunol; 1993 Jun; 150(12):5361-70. PubMed ID: 8515064
[TBL] [Abstract][Full Text] [Related]
19. Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis.
Lu J; Yu Y; Zhu I; Cheng Y; Sun PD
Proc Natl Acad Sci U S A; 2014 Apr; 111(14):5189-94. PubMed ID: 24706838
[TBL] [Abstract][Full Text] [Related]
20. Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A.
Aguilera JJ; Zhang F; Beaudet JM; Linhardt RJ; Colón W
Biochimie; 2014 Sep; 104():70-80. PubMed ID: 24878279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
